Piper Sandler Companies logo PIPR - Piper Sandler Companies

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 2
HOLD 9
SELL 0
STRONG
SELL
0
| PRICE TARGET: $96.63 DETAILS
HIGH: $97.00
LOW: $96.25
MEDIAN: $96.62
CONSENSUS: $96.63
UPSIDE: 25.26%

Stock News

Piper Sandler Expands Restructuring Group With the Addition of John D'Amico

Piper Sandler Expands Restructuring Group With the Addition of John D'Amico

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John D'Amico as a managing director in the Piper Sandler restructuring group. D'Amico will be focused on advising a broad range of clients in complex restructurings and special situation transactions.With approximately 25 years of investment banking and corporate advisory experience, D'Amico has advised companies, boards of directors, official and ad hoc creditor com.

Jun 29, 2026 05:00 AM businesswire.com
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus

Financing led by Piper Sandler Merchant Banking, with participation from new investors Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic Participation by existing investors, including Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds Proceeds will support the conclusion of the STRIDE pivotal trial, continued operational scale-up, advancement of regulatory work toward a future Premarket Approval (PMA) submission to the FDA, and preparations for US commercialization Board strengthened with addition of Kevin Conroy as Lead Independent Director, Christopher Geyen as Chair of the Audit Committee, and Tom Schnettler representing Series C investors BOSTON, June 4, 2026 /PRNewswire/ -- CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced it has successfully completed the initial closing of an $85 million Series C financing. Piper Sandler Merchant Banking led the financing with participation from Johnson & Johnson Innovation – JJDC, Inc., Johnson & Johnson's corporate venture capital arm, and Medtronic, along with existing investors Bain Capital Life Sciences and Perceptive Xontogeny Venture Funds.

Jun 04, 2026 02:34 AM prnewswire.com
Piper Sandler Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business

Piper Sandler Appoints New Co-Heads of Services and Industrials Investment Banking and Enhances Focus on Private Equity Advisory Business

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, has named Rob Parker and Tripp Griffin as co-heads of services and industrials investment banking. Matt Sznewajs and John Tye, current co-heads of the services & industrials team, have been appointed vice chairmen of investment banking, and co-heads of private equity advisory. David Lee will join Sznewajs and Tye in leading the firm's private equity advisory effort while continuing to lead Piper S.

Jun 02, 2026 05:00 AM businesswire.com
Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr.

May 11, 2026 05:01 AM businesswire.com

Price Targets